Adaptyv gets $40M to turn Claude’s protein designs into experiments
Signals InboxAugust 25, 2026Synthetic Biology
The funding matters because investors are paying for a very specific market shift. AI is closing the wet-lab loop.
We raised a $40M Series A to build the automated lab for agentic biology.
— Adaptyv Bio (@adaptyvbio) August 25, 2026
Last week, we shared the work we did with @Anthropic: Claude designed proteins, sent them to our automated wet lab, and got real experimental data back.
We believe this is where biology is going: AI… pic.twitter.com/XX7QS5pr4V
Q1What did Adaptyv announce?
According to the official source, adaptyv Bio says it raised a $40 million Series A to build an automated lab for agentic biology. In recent work with Anthropic, Claude designed proteins, sent designs into Adaptyv's automated wet lab, and received experimental results back.
Q2Why is the closed loop important?
Most biology models stop at prediction. Connecting a model directly to experiments lets an agent generate a design, test it, learn from the result, and run another cycle with much less human coordination.
Q3What is the bottleneck now?
Biology still moves at physical speed. Robots, assays, cell growth, and measurement quality determine how quickly an AI system can actually learn from experiments.
Q4What does the $40M fund?
The capital is a bet that automated wet labs become infrastructure for AI-native biotech, not just internal tools for one drug program. If that happens, experimental throughput becomes a software-like competitive advantage.